219.68
price down icon2.52%   -5.69
after-market Handel nachbörslich: 220.03 0.35 +0.16%
loading

Finanzdaten der Abbvie Inc-Aktie (ABBV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.34%
16,618.00
15,776.00 15,423.00 13,343.00 14,460.00
Cost Of Revenue
14.18%
4,552.00
5,304.00 4,346.00 4,002.00 4,212.00
Gross Profit
15.22%
12,066.00
10,472.00 11,077.00 9,341.00 10,248.00
Operating Expenses
12.21%
7,522.00
8,568.00 6,183.00 5,608.00 6,417.00
Interest Income/Expense
3.38%
714.00
739.00 740.00 700.00 720.00
Benefits Costs and Expenses
100.00%
-
15,062.00 13,869.00 11,682.00 12,376.00
Costs And Expenses
100.00%
-
13,872.00 10,529.00 9,610.00 10,629.00
Operating Income/Loss
138.66%
4,544.00
1,904.00 4,894.00 3,733.00 3,831.00
Income/Loss From Continuing Operations Before Tax
2,227%
16,618.00
714.00 1,554.00 1,661.00 2,084.00
Income Tax Expense/Benefit, Deferred
299.48%
-385.00
193.00 -272.00 -28.00 -277.00
Income Tax Expense/Benefit
62.17%
853.00
526.00 613.00 372.00 520.00
Income/Loss From Continuing Operations After Tax
865.96%
1,816.00
188.00 941.00 1,289.00 1,564.00
Net Income/Loss
865.96%
1,816.00
188.00 941.00 1,289.00 1,564.00
Preferred Stock Dividends And Other Adjustments
100.00%
-
10.00 10.00 10.00 10.00
Attributable To Noncontrolling Interest
100.00%
-
2.00 3.00 3.00 3.00
Basic Average Shares
100.00%
-
1,769.00 1,768.00 1,768.00 1,769.00
Diluted Average Shares
99.94%
1.00
1,772.00 1,771.00 1,772.00 1,772.00
Basic Earnings Per Share
920.00%
1.02
0.10 0.52 0.72 0.88
Diluted Earnings Per Share
920.00%
1.02
0.10 0.52 0.72 0.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
10.00 10.00 10.00 10.00
drug_manufacturers_general AZN
$189.90
price down icon 1.35%
drug_manufacturers_general NVS
$153.44
price down icon 0.53%
drug_manufacturers_general MRK
$115.61
price down icon 0.26%
$366.21
price down icon 0.43%
drug_manufacturers_general JNJ
$241.52
price down icon 0.21%
Kapitalisierung:     |  Volumen (24h):